Background*

Mr. Daniel O'Day has been the Chief Operating Officer of Roche Pharma AG since September 1, 2012. Mr. O'Day served as the Chief Operating Officer of Roche Diagnostics GmbH from 2010 to 2012. Mr. O'Day served as the Chief Executive Officer and President of Roche Molecular Diagnostics at Roche Carolina Inc. and Roche Holding AG from 2006 to 2010. Mr. O'Day served as the Chief Executive Officer and President of Roche Diagnostics GmbH. Mr. O'Day was with Roche for more than ... 20 years, following positions of increasing responsibility in sales, marketing, and human resources. He began his career in 1987 at Roche in the U.S. Pharmaceuticals organization in Sales and Marketing. Afterwards, he held various positions in Roche Pharma in Switzerland, Japan, and Denmark. In 2006 Mr. O'Day joined Roche Diagnostics and became Head of the Business Area Molecular Diagnostics. Since January 1 2010, he served as Chief Operating Officer for Roche's global diagnostics business. He worked 11 years managing international assignments that included life cycle leadership at Roche Pharmaceuticals in Basel, Switzerland; strategic planning and involvement in the Chugai merger in Tokyo, Japan; and, prior to joining the molecular diagnostics unit, served as General Manager of Roche Pharmaceuticals in Denmark. He has been a Director of Chugai Pharmaceutical Co. Ltd. since March 27, 2013. He serves as a Director of Genentech, Inc. and California Healthcare Institute. Mr. O'Day holds an undergraduate degree in Biology from Georgetown University and a Master of Business Administration from Columbia University.

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.